申请人:Millennium Pharmaceuticals, Inc.
公开号:US20030225288A1
公开(公告)日:2003-12-04
Disclosed are novel compounds and a method of treating inflammatory diseases. The method comprises administering to an individual in need an effective amount of an imidazolidine compound represented by Structural Formula (I):
1
or a physiologically acceptable salt thereof.
揭示了一种治疗炎症性疾病的新化合物和方法。该方法包括向需要的个体施用由结构式(I)表示的咪唑啉化合物或其生理上可接受的盐的有效量。